Allogeneic hematopoietic cell transplantation: the state of the art
B Gyurkocza, A Rezvani, RF Storb - Expert review of hematology, 2010 - Taylor & Francis
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative procedure for a
variety of hematologic malignancies. The field has evolved substantially over the past …
variety of hematologic malignancies. The field has evolved substantially over the past …
How much blood is needed?
E Seifried, H Klüter, C Weidmann… - Vox …, 2011 - Wiley Online Library
Demographic changes in developed countries as their populations age lead to a steady
increase in the consumption of standard blood components. Complex therapeutic …
increase in the consumption of standard blood components. Complex therapeutic …
Trends in United States blood collection and transfusion: results from the 2013 AABB blood collection, utilization, and patient blood management survey
B Whitaker, S Rajbhandary, S Kleinman, A Harris… - …, 2016 - Wiley Online Library
BACKGROUND AABB surveyed AABB institutional members about their 2013 blood
collection, transfusion, and patient blood management (PBM) programs. Results were …
collection, transfusion, and patient blood management (PBM) programs. Results were …
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic …
Context A minimally toxic nonmyeloablative regimen was developed for allogeneic
hematopoietic cell transplantation (HCT) to treat patients with advanced hematologic …
hematopoietic cell transplantation (HCT) to treat patients with advanced hematologic …
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and …
D Niederwieser, M Maris, JA Shizuru… - Blood, The Journal …, 2003 - ashpublications.org
Toxicities of high-dose conditioning regimens have limited the use of conventional unrelated
donor hematopoietic cell transplantation (HCT) to younger, medically fit patients. Based on …
donor hematopoietic cell transplantation (HCT) to younger, medically fit patients. Based on …
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
DG Maloney, AJ Molina, F Sahebi… - Blood, 2003 - ashpublications.org
The full potential of a graft-versusmyeloma effect after allogeneic hematopoietic cell
transplantation (HCT) for patients with multiple myeloma (MM) has not been realized …
transplantation (HCT) for patients with multiple myeloma (MM) has not been realized …
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in …
B Bolwell, R Sobecks, B Pohlman… - Bone marrow …, 2004 - nature.com
Cyclosporine (CSP) and short course methotrexate (MTX) have been the gold standard for
GVHD prophylaxis for decades. Problems associated with MTX include increased time to …
GVHD prophylaxis for decades. Problems associated with MTX include increased time to …
Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation
SD Rowley, ML Donato, P Bhattacharyya - Bone marrow …, 2011 - nature.com
Transplantation of hematopoietic progenitor cells from red cell-incompatible donors occurs
in 30–50% of patients. Immediate and delayed hemolytic transfusion reactions are expected …
in 30–50% of patients. Immediate and delayed hemolytic transfusion reactions are expected …
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation
JA Pérez‐Simón, M Díez‐Campelo… - British journal of …, 2005 - Wiley Online Library
The graft‐versus‐host disease (GVHD) characteristics of 150 consecutive patients
undergoing reduced intensity conditioning allogeneic (allo‐RIC) transplants and 88 patients …
undergoing reduced intensity conditioning allogeneic (allo‐RIC) transplants and 88 patients …
[HTML][HTML] Allogeneic hematopoietic cell transplantation for acute myeloid leukemia
P Vyas, FR Appelbaum, C Craddock - Biology of Blood and Marrow …, 2015 - Elsevier
Allogeneic stem cell transplantation is an increasingly important treatment option in the
management of adult acute myeloid leukemia (AML). The major causes of treatment failure …
management of adult acute myeloid leukemia (AML). The major causes of treatment failure …